J
Jerrold M. Liesch
Researcher at Merck & Co.
Publications - 93
Citations - 5942
Jerrold M. Liesch is an academic researcher from Merck & Co.. The author has contributed to research in topics: Farnesyl Protein Transferase & Streptomyces hygroscopicus. The author has an hindex of 35, co-authored 93 publications receiving 5777 citations.
Papers
More filters
Journal ArticleDOI
Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent.
Alfred W. Alberts,Julie S. Chen,G Kuron,V Hunt,Jesse W. Huff,Carl H. Hoffman,John W. Rothrock,Lopez Maria B,Henry Joshua,Elbert E. Harris,Arthur A. Patchett,R L Monaghan,S Currie,E Stapley,George Albers-Schonberg,Otto D. Hensens,J Hirshfield,Karst Hoogsteen,Jerrold M. Liesch,James P. Springer +19 more
TL;DR: It was shown that mevinolin was an orally active cholesterol-lowering agent in the dog and orally administered sodium mevinolinate was an active inhibitor of cholesterol synthesis in an acute assay.
Journal Article
Epothilones, a New Class of Microtubule-stabilizing Agents with a Taxol-like Mechanism of Action
Daniel M. Bollag,Patricia A. McQueney,Jian Zhu,Otto D. Hensens,Lawrence R. Koupal,Jerrold M. Liesch,Michael A. Goetz,Elias Lazarides,Catherine M. Woods +8 more
TL;DR: Epothilones represent a novel structural class of compounds, the first to be described since the original discovery ofTaxol, which not only mimic the biological effects of taxol but also appear to bind to the same microtubule-binding site as taxol.
Journal ArticleDOI
A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus.
RS Chang,VJ Lotti,Richard L. Monaghan,Jerome Birnbaum,Edward O. Stapley,Michael A. Goetz,George Albers-Schonberg,Arthur A. Patchett,Jerrold M. Liesch,Otto D. Hensens +9 more
TL;DR: A new, competitive, nonpeptide cholecystokinin (CCK) antagonist, asperlicin, was isolated from the fungus Aspergillus alliaceus and has 300 to 400 times the affinity for pancreatic, ileal, and gallbladder CCK receptors than proglumide, a standard agent of this class.
Journal ArticleDOI
Pharmaceuticals from cultured algae
Robert E. Schwartz,Charles F. Hirsch,David F. Sesin,James E. Flor,Michel Chartrain,Robert E. Fromtling,Guy H. Harris,Michael J. Salvatore,Jerrold M. Liesch,Katherine Yudin +9 more
TL;DR: Screening of these groups for biologically active components has lead to the isolation of pachydictyol and caulerpenyne from cultured macroalgae, while a series of hapalindoles and an antifungal depsipeptide have been isolated from cyanobacteria.
Journal ArticleDOI
Biosynthesis of fluorothreonine and fluoroacetic acid by the thienamycin producer, Streptomyces cattleya.
Minoru Sanada,Tetsuji Miyano,Shuichi Iwadare,Joanne M. Williamson,Byron H. Arison,Jack L. Smith,Alan W. Douglas,Jerrold M. Liesch,Edward S. Inamine +8 more
TL;DR: An antimetabolite, THX, was isolated from fermentation broths of the thienamycin producer, Streptomyces cattleya, when the organism was grown in the presence of a fluorine-containing substrate.